Advanced Search
Contact | Corporate | Help

A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

Sponsors:
  • Seattle Genetics, Inc.
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Non-Hodgkin
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: SGN-40
  • Drug: placebo
  • Drug: rituximab
  • Drug: etoposide
  • Drug: carboplatin
  • Drug: ifosfamide
Enrollment:
224

Additional information about NCT00529503.


SourceSolution © 2008-2012